Strong Demand Could Cushion the Impact of a Potential Oncoclínicas Office Exit in Faria Lima
The company has announced no plans to vacate; low structural vacancy and positive net absorption favor finding replacement tenants in the district
Oncoclínicas’ debt renegotiation, conducted through an out-of-court restructuring process, is raising questions about whether the company will retain its high-end offices, particularly in São Paulo’s Faria Lima district. Local market conditions, however, could make it easier to find a replacement tenant if the company leaves, limiting the impact on Stan, which owns the space the healthcare group occupies at F.L. 4300.
The company leases approximately 1,900 square meters in the building, with estimated occupancy costs of R$619,200 per month, or R$7.4 million annually, based on market rates tracked by SiiLA’s Market Analytics. This estimate does not necessarily reflect the company’s actual contractual payments, which depend on the terms negotiated by the parties, including any lease renewals.
An exit remains hypothetical. Oncoclínicas has not announced plans to leave the building or its other offices in São Paulo’s Vila Leopoldina neighborhood and Botafogo, within Rio de Janeiro’s Orla office submarket. If it vacates the Faria Lima space, vacancy at F.L. 4300 would rise from its current 11.7% to 24.7%.
Although that would increase availability in the building, district-level indicators suggest the market has the capacity to absorb the space. According to SiiLA’s Market Analytics, Faria Lima’s vacancy rate stood at 9.1% in the third quarter of 2026. Structural vacancy, defined as space that has remained continuously vacant for more than three years, accounted for just 0.4% of inventory, the lowest rate in the city.
The gap shows that while space is available, little remains unoccupied for extended periods. Another sign of strong demand is the district’s positive net absorption, the net change in occupied space, which totaled 19,600 square meters during the quarter, even as 11,800 square meters of new inventory entered the market.
Taken together, the figures point to favorable conditions for finding a new tenant should the oncology group decide to leave. The time needed to restore rental income, however, would depend on the property’s features and the lease terms offered.
Asked whether the situation raised any concerns, Stan Empreendimentos told REsource that, as a matter of policy, it does not comment on partners or tenants and therefore preferred not to address the matter at this time.
Why Might Oncoclínicas Vacate Its Offices?
In a material fact disclosure released yesterday, October 15, the healthcare company said the court had ordered the companies involved in the restructuring proceedings to state how they intended to move forward with the debt negotiations.
According to the disclosure, the 90-day deadline to demonstrate support from creditors holding more than half the value of the claims in each category covered by the plan expired on Tuesday, October 13. The judge granted the companies an additional 15 days to demonstrate the required support or submit another request regarding how the proceedings should continue.
The disclosure also stated that, as of its release, the ruling had not yet been published in Brazil’s electronic judicial gazette, meaning the new deadline had not begun to run.
Oncoclínicas said it would notify the market of the start and end dates. The document did not clarify whether the necessary creditor support had already been secured.
Jean Lucas Paiva, a corporate restructuring specialist and owner and partner at Consult Seven, believes the expiration of the deadline without proof of the required creditor support makes clear that the parties remain far from even a minimally workable agreement.
“In practice, this reflects a classic disagreement over haircuts, or reductions in the amount owed, grace periods, repayment schedules, and collateral,” he explains.
If the company fails to demonstrate creditor approval within the new court-imposed deadline, it will lose the protection that had stayed collection efforts and asset freezes. Creditors would then be able to immediately enforce security interests, seek asset attachments, and collect overdue debts.
Oncoclínicas did not respond to REsource’s request for comment by publication time. The company remains welcome to provide a statement.
